"Call us now!"

During the past decade, R.S. McLaughlin Durham Regional Cancer Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "R.S. McLaughlin Durham Regional Cancer Centre" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "British Columbia Cancer Agency" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Trans Tasman Radiation Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "R.S. McLaughlin Durham Regional Cancer Centre" are "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Metastatic Breast Cancer" (1 trials), "Non Squamous Lung Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "R.S. McLaughlin Durham Regional Cancer Centre" in a lesser frequency.

Most popular intervention types in "R.S. McLaughlin Durham Regional Cancer Centre" are "Drug" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "6000 cGy/20 fractions in 4 weeks" (1 trials), "7800 cGy/39 fractions in 8 weeks" (1 trials), "Docetaxel" (1 trials), "Fulvestrant + Placebo" (1 trials) and "Fulvestrant + ZACTIMA" (1 trials). Other intervention names were less common.

The vast majority of trials in "R.S. McLaughlin Durham Regional Cancer Centre" are 3 trials for "Female" genders, 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "R.S. McLaughlin Durham Regional Cancer Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in R.S. McLaughlin Durham Regional Cancer Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in R.S. McLaughlin Durham Regional Cancer Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".